133 related articles for article (PubMed ID: 22984676)
1. Comparison of elective inguinal node irradiation techniques in anal cancer.
Cha J; Seong J; Keum KC; Lee CG; Koom WS
Radiat Oncol J; 2011 Dec; 29(4):236-42. PubMed ID: 22984676
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a 36 Gy elective node irradiation dose in anal cancer.
Lépinoy A; Lescut N; Puyraveau M; Caubet M; Boustani J; Lakkis Z; Fantoli M; Buffet-Miny J; Kim S; Bednarek C; Maingon P; Créhange G; Bosset JF
Radiother Oncol; 2015 Aug; 116(2):197-201. PubMed ID: 26277433
[TBL] [Abstract][Full Text] [Related]
3. Reduced radiation dose for elective nodal irradiation in node-negative anal cancer: back to the roots?
Henkenberens C; Meinecke D; Michael S; Bremer M; Christiansen H
Strahlenther Onkol; 2015 Nov; 191(11):845-54. PubMed ID: 26307627
[TBL] [Abstract][Full Text] [Related]
4. Can we omit prophylactic inguinal nodal irradiation in anal cancer patients?
Kim H; Park HC; Yu JI; Choi DH; Ahn YC; Kim ST; Park JO; Park YS; Kim HC
Radiat Oncol J; 2015 Jun; 33(2):83-8. PubMed ID: 26157677
[TBL] [Abstract][Full Text] [Related]
5. Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness.
Ferrigno R; Nakamura RA; Dos Santos Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV; Filho WJ; Lopes A
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1136-42. PubMed ID: 15752894
[TBL] [Abstract][Full Text] [Related]
6. Epidermoid carcinoma of the anal canal. Results of curative-intent radiation therapy in a series of 270 patients.
Touboul E; Schlienger M; Buffat L; Lefkopoulos D; Pène F; Parc R; Tiret E; Gallot D; Malafosse M; Laugier A
Cancer; 1994 Mar; 73(6):1569-79. PubMed ID: 8156483
[TBL] [Abstract][Full Text] [Related]
7. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
8. Phase I dose escalating trial of hyperfractionated pre-operative chemoradiation for locally advanced rectal cancer.
Movsas B; Hanlon AL; Lanciano R; Scher RM; Weiner LM; Sigurdson ER; Hoffman JP; Eisenberg BL; Cooper HS; Provins S; Coia LR
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):43-50. PubMed ID: 9747818
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous Integrated Boost (SIB) Versus Sequential Boost in Anal Cancer Patients: A Single-Center Experience.
Khosla D; Kapoor R; Dey T; Kataria V; Singh R; Kumar D; Oinam AS; Gupta R; Rana SS; Shah J; Singh H; Irrinki S; Madan R
J Gastrointest Cancer; 2024 Jan; ():. PubMed ID: 38236375
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of dosimetric predictors of toxicity after IMRT with concurrent chemotherapy for anal cancer.
Lukovic J; Hosni A; Liu A; Chen J; Tadic T; Patel T; Li K; Han K; Lindsay P; Craig T; Brierley J; Barry A; Wong R; Ringash J; Dawson LA; Kim JJ
Radiother Oncol; 2023 Jan; 178():109429. PubMed ID: 36455685
[TBL] [Abstract][Full Text] [Related]
11. Irradiating the groin nodes without breaking a leg: a comparison of techniques for groin node irradiation.
Gilroy JS; Amdur RJ; Louis DA; Li JG; Mendenhall WM
Med Dosim; 2004; 29(4):258-64. PubMed ID: 15528067
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer.
Han K; Cummings BJ; Lindsay P; Skliarenko J; Craig T; Le LW; Brierley J; Wong R; Dinniwell R; Bayley AJ; Dawson LA; Ringash J; Krzyzanowska MK; Moore MJ; Chen EX; Easson AM; Kassam Z; Cho C; Kim J
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):587-94. PubMed ID: 25194664
[TBL] [Abstract][Full Text] [Related]
13. Can the radiation dose to CT-enlarged but FDG-PET-negative inguinal lymph nodes in anal cancer be reduced?
Mai SK; Welzel G; Hermann B; Wenz F; Haberkorn U; Dinter DJ
Strahlenther Onkol; 2009 Apr; 185(4):254-9. PubMed ID: 19370429
[TBL] [Abstract][Full Text] [Related]
14. Elective inguinal node irradiation in early-stage T2N0 anal cancer: prognostic impact on locoregional control.
Zilli T; Betz M; Bieri S; Ris F; Roche B; Roth AD; Allal AS
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):60-6. PubMed ID: 23608237
[TBL] [Abstract][Full Text] [Related]
15. Inguinal lymph node recurrence in the untreated groin of patients with anal carcinoma.
Blinde SE; Schasfoort R; Mens JW; Verhoef C; Olofsen M; Nuyttens JJ
Dis Colon Rectum; 2014 May; 57(5):578-84. PubMed ID: 24819097
[TBL] [Abstract][Full Text] [Related]
16. Chemoradiation for High-grade Neuroendocrine Carcinoma of the Rectum and Anal Canal.
Voong KR; Rashid A; Crane CH; Minsky BD; Krishnan S; Yao JC; Wolff RA; Skibber JM; Feig BW; Chang GJ; Das P
Am J Clin Oncol; 2017 Dec; 40(6):555-560. PubMed ID: 26237193
[TBL] [Abstract][Full Text] [Related]
17. Pencil Beam Scanning (PBS) Intensity-Modulated Proton Therapy (IMPT) Chemoradiotherapy for Anal Canal Cancer-Single Institution Experience.
Vítek P; Kubeš J; Vondráček V; Andrlik M; Navrátíl M; Zapletal R; Haas A; Dědečková K; Ondrová B; Grebenyuk A; Rosina J
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008349
[No Abstract] [Full Text] [Related]
18. Simultaneous integrated boost-intensity modulated radiation therapy with concomitant capecitabine and mitomycin C for locally advanced anal carcinoma: a phase 1 study.
Deenen MJ; Dewit L; Boot H; Beijnen JH; Schellens JH; Cats A
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):e201-7. PubMed ID: 23517808
[TBL] [Abstract][Full Text] [Related]
19. High-dose whole abdominal and pelvic irradiation for treatment of ovarian carcinoma: long-term toxicity and outcomes.
Firat S; Murray K; Erickson B
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):201-7. PubMed ID: 12909234
[TBL] [Abstract][Full Text] [Related]
20. T1-2 anal carcinoma requires elective inguinal radiation treatment--the results of Trans Tasman Radiation Oncology Group study TROG 99.02.
Matthews JH; Burmeister BH; Borg M; Capp AL; Joseph D; Thompson KM; Thompson PI; Harvey JA; Spry NA
Radiother Oncol; 2011 Jan; 98(1):93-8. PubMed ID: 21109321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
